JPRN-UMIN000030864招募中未知
A prospective study of salvage radiotherapy combined with horrmone therapy for high-risk recurrent prostate cancer after radical prostatectomy - The SAHOP study
Department of Urology, Nara Medical University0 个研究点目标入组 100 人开始时间: 2018年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Inappropriate for the enrolment by the judgement of the physician
研究者
相似试验
招募中
2 期
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
招募中
不适用
Prospective observational study of radiotherapy with respiratory migration countermeasures for breast cancerBreast cancerJPRN-UMIN000045576Kagawa University Hospital30
招募中
1 期
A confirmatory trial on concomitant radiotherapy and transcatheter arterial embolization to reduce skeletal-related events (SRE) related to bone metastasis from renal cell carcinoma.Bone metastasis from renal cell carcinomarenal cell carcinoma, skeletal-related eventsJPRN-jRCT1071210107Joichi Heianna52
已完成
不适用
Phase I trial evaluating combined radiotherapy with Panitumumab (Vectibix®) in patients with muscle invasive transitional cell carcinoma of the bladder10004994Bladder carcinomabladder cancerNL-OMON34833Antoni van Leeuwenhoek Ziekenhuis31
已完成
2 期
Phase II study of palliative radiotherapy combined with Zoledronic Acid Hydrate for metastatic bone tumor from renal cell carcinomaRenal cancerJPRN-UMIN000007836Shizuoka Cancer Center Japanese Radiation Oncology Study Group30